Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
Resmed (NYSE: RMD) will report first quarter fiscal 2026 results on Thursday, October 30, 2025 after NYSE close. Management will host a live webcast at 1:30 p.m. PDT / 4:30 p.m. EDT (London 8:30 p.m. GMT; Sydney Oct 31 7:30 a.m. AEDT) to discuss financial and operational results and other material information.
Investors can access the webcast at https://investor.resmed.com. A replay will be available on the investor relations site about two hours after the webcast. A phone replay runs from October 30, 2025 through November 13, 2025 with U.S. and international dial-ins and conference ID 13756529.
Resmed (NYSE: RMD) riporterà i risultati del primo trimestre fiscale 2026 giovedì 30 ottobre 2025 dopo la chiusura della NYSE. Il management ospiterà una trasmissione in diretta alle 13:30 PDT / 16:30 EDT (Londra 20:30 GMT; Sydney 31 ottobre 7:30 AEDT) per discutere i risultati finanziari e operativi e altre informazioni rilevanti.
I investitori possono accedere alla webcast su https://investor.resmed.com. Una replica sarà disponibile sul sito delle relazioni con gli investitori circa due ore dopo la webcast. Una replica telefonica sarà disponibile dal 30 ottobre 2025 al 13 novembre 2025 con numeri internazionali e statunitensi e conference ID 13756529.
Resmed (NYSE: RMD) reportará los resultados del primer trimestre fiscal de 2026 el jueves 30 de octubre de 2025 después del cierre de la NYSE. La dirección celebrará una transmisión en vivo a las 1:30 p.m. PDT / 4:30 p.m. EDT (Londres 8:30 p.m. GMT; Sídney 31 de octubre 7:30 a.m. AEDT) para discutir resultados financieros y operativos y otra información material.
Los inversores pueden acceder a la transmisión en https://investor.resmed.com. Una repetición estará disponible en el sitio de relaciones inversoras aproximadamente dos horas después de la transmisión. Una repetición telefónica estará disponible desde el 30 de octubre de 2025 hasta el 13 de noviembre de 2025, con marcaciones de EE. UU. e internacionales y conference ID 13756529.
Resmed (NYSE: RMD)는 2026 회계연도 1분기 실적을 2025년 10월 30일 목요일 NYSE 종가 이후 발표합니다. 경영진은 태평양 표준시 오후 1시 30분 / 동부표준시 오후 4시 30분에 라이브 웹캐스트를 주최할 예정이며 (런던 GMT 20:30; 시드니 31일 AEDT 07:30) 재무 및 운영 실적 및 기타 중요한 정보를 논의합니다.
투자자들은 https://investor.resmed.com에서 웹캐스트에 접속할 수 있습니다. 웹캐스트 약 두 시간 후 투자자 관계 사이트에서 재생이 제공됩니다. 전화 재생은 2025년 10월 30일부터 2025년 11월 13일까지 미국 및 국제 다이얼인과 conference ID 13756529로 이용 가능합니다.
Resmed (NYSE: RMD) publiera les résultats du premier trimestre fiscal 2026 le jeudi 30 octobre 2025 après la clôture de la NYSE. La direction organisera une webdiffusion en direct à 13h30 PDT / 16h30 EDT (Londres 20h30 GMT ; Sydney 31 octobre 7h30 AEDT) pour discuter des résultats financiers et opérationnels et d'autres informations importantes.
Les investisseurs peuvent accéder à la webdiffusion sur https://investor.resmed.com. Une rediffusion sera disponible sur le site des relations investisseurs environ deux heures après la diffusion. Une rediffusion téléphonique est disponible du 30 octobre 2025 au 13 novembre 2025 avec des numéros internationaux et américains et conference ID 13756529.
Resmed (NYSE: RMD) wird die Ergebnisse des ersten Quartals des Geschäftsjahres 2026 am Donnerstag, 30. Oktober 2025 nach Börsenschluss der NYSE bekannt geben. Die Geschäftsführung wird um 13:30 PDT / 16:30 EDT eine Live-Webcast veranstalten (London 20:30 GMT; Sydney 31. Oktober 7:30 AEDT) um finanzielle und operative Ergebnisse sowie weitere wesentliche Informationen zu diskutieren.
Investoren können über die Webcast-Seite auf https://investor.resmed.com zugreifen. Eine Wiederholung wird etwa zwei Stunden nach dem Webcast auf der Investor-Relations-Seite verfügbar sein. Eine telefonische Wiederholung läuft vom 30. Oktober 2025 bis zum 13. November 2025 mit internationalen und US-Wähleinwendungen und conference ID 13756529.
Resmed (NYSE: RMD) ستعلن عن نتائج الربع الأول من السنة المالية 2026 في الخميس 30 أكتوبر 2025 بعد إغلاق سوق نيويورك. ستعقد الإدارة بثاً مباشراً في الساعة 1:30 ظهرًا بتوقيت المحيط الهادئ / 4:30 مساءً بتوقيت شرق الولايات المتحدة (لندن 8:30 مساءً GMT؛ سيدني 31 أكتوبر 7:30 صباحاً AEDT) لمناقشة النتائج المالية والتشغيلية ومعلومات مادية أخرى.
يمكن للمستثمرين الوصول إلى البث عبر https://investor.resmed.com. ستكون هناك إعادة مشاهدة متاحة على موقع العلاقات الاستثمارية بعد حوالي ساعتين من البث. وتتوفر إعادة هاتفية من 30 أكتوبر 2025 حتى 13 نوفمبر 2025 مع خطوط الاتصالات الأمريكية والدولية ومعرف المؤتمر 13756529.
Resmed (NYSE: RMD) 将在2026财年第一季度于2025年10月30日星期四在纽约证券交易所收盘后公布业绩。管理层将于太平洋夏令时下午1:30 / 东部夏令时下午4:30举行现场直播网络广播（伦敦格林威治时间20:30；悉尼10月31日7:30 AEDT）以讨论财务与运营业绩及其他重要信息。
投资者可通过https://investor.resmed.com访问网络广播。网络广播约在广播结束后两小时内在投资者关系网站提供重播。电话重播自2025年10月30日起至2025年11月13日止，提供美国及国际拨入和会议ID 13756529。
- None.
- None.
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • | Location: | https://investor.resmed.com | |
| • | Date: | Thursday, October 30, 2025 | |
| • | Time: | 1:30 p.m. PDT / 4:30 p.m. EDT | |
| • | International: | London, Thursday, October 30, 2025, 8:30 p.m. GMT Sydney, Friday, October 31, 2025, 7:30 a.m. AEDT | |
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 30, 2025, until November 13, 2025, at:
| • | U.S.: +1 877.660.6853 | |
| • | International: +1 201.612.7415 | |
| • | Conference ID: 13756529 | |
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
| For investors +1 858.221.3304 investorrelations@Resmed.com | For media +1 619.510.1281 news@Resmed.com |
FAQ
When will Resmed (RMD) report Q1 fiscal 2026 earnings?
What time is the Resmed (RMD) earnings webcast on October 30, 2025?
Where can investors watch the Resmed (RMD) Q1 FY2026 webcast?
When will the replay of Resmed's (RMD) earnings webcast be available?
How can I access the phone replay for Resmed (RMD) Q1 FY2026 results?
Will Resmed (RMD) use an outside phone line for the live earnings call?
